Description

RITONATERIS LP is a combination antiviral medication containing Lopinavir (200 mg) and Ritonavir (50 mg), formulated to effectively manage and control HIV-1 infection (Human Immunodeficiency Virus). Manufactured by Steris Healthcare Pvt. Ltd., this advanced antiretroviral therapy (ART) works by reducing the amount of virus in the blood, thereby improving immune function and slowing the progression of HIV-related diseases. Lopinavir and Ritonavir belong to a class of medicines known as protease inhibitors. Ritonavir boosts the effectiveness of Lopinavir by increasing its concentration in the bloodstream, allowing for better viral suppression and enhanced therapeutic outcomes. With regular use and adherence to prescribed treatment, RITONATERIS LP helps patients lead healthier, more active lives by keeping the infection under control. Uses RITONATERIS LP is primarily used in the management of HIV-1 infection and is prescribed as part of combination antiretroviral therapy (ART). Its main uses include: Treatment of HIV-1 Infection: Helps control the replication of the HIV virus in the body. Boosts Immune Function: Supports the immune system in fighting off infections. Reduces Viral Load: Decreases the amount of HIV in the blood, improving quality of life. Prevention of HIV-related Complications: Helps delay or prevent conditions associated with AIDS. RITONATERIS LP is not a cure for HIV, but it is a crucial component of long-term HIV management and viral suppression therapy. Benefits Powerful Dual Action: Combines Lopinavir and Ritonavir for maximum antiviral effect. Enhanced Drug Efficacy: Ritonavir boosts Lopinavir’s levels, improving effectiveness. Improves Quality of Life: Helps maintain immune strength and reduces illness frequency. Slows Disease Progression: Controls viral load and delays advancement to AIDS. Trusted Antiretroviral Therapy: Meets international quality standards for HIV management. Patients taking RITONATERIS LP as part of combination therapy often experience sustained viral suppression, improved CD4 cell counts, and a stronger immune response over time. Dosage Recommended Dose for Adults: The usual dose is Lopinavir 400 mg + Ritonavir 100 mg (i.e., two RITONATERIS LP tablets) taken twice daily. Alternatively, the dose may be 800 mg + 200 mg once daily, depending on the doctor’s recommendation. Administration: Take the tablets with food to enhance absorption. Swallow the tablets whole with water. Maintain consistent timing between doses for best results. Do not skip or stop medication without consulting your healthcare provider. The exact dosage may vary depending on the patient’s health condition, previous treatment response, and concurrent medications. Side Effects Like other antiretroviral drugs, RITONATERIS LP may cause mild to moderate side effects in some patients. Common side effects include: Nausea or vomiting Diarrhea or abdominal pain Headache or tiredness Elevated cholesterol or triglyceride levels Mild skin rash Rare but serious side effects may include liver dysfunction, pancreatitis, or changes in heart rhythm. Always report unusual or persistent symptoms to your healthcare provider immediately. Conclusion RITONATERIS LP (Lopinavir 200 mg + Ritonavir 50 mg) by Steris Healthcare Pvt. Ltd. is a trusted and effective antiretroviral formulation that plays a vital role in the management of HIV-1 infection. Its dual mechanism ensures potent viral suppression while boosting the immune system’s ability to defend the body against infections.